A T-cell vaccine is a vaccine designed to induce protective T-cells. [1]
T-cell vaccines are designed to induce cellular immunity. They are also referred to as cell-mediated immune (CMI) vaccines. [2]
It is thought that they can be more effective than conventional B-cell vaccines for protection from microbes that hide inside host cells, and viruses (such as HIV or influenza) that mutate rapidly.[ citation needed]
T-cell vaccines underwent clinical trials for HIV/AIDS. [3]
As of July 2012 [update] none have been approved. [4]
As December 2020, The Pfizer-BioNTech Covid jab passed the FDA's emergency use authorization [5] and became the first FDA authorized T cell vaccine. [6] [7]
References
- ^ Robinson, Harriet L.; Amara, Rama Rao (2005). "T cell vaccines for microbial infections". Nature Medicine. 11 (4s): S25–S32. doi: 10.1038/nm1212. PMID 15812486. S2CID 205384682.
- ^ Buchbinder, SP; Mehrotra, DV; Duerr, A; Fitzgerald, DW; Mogg, R; Li, D; Gilbert, PB; Lama, JR; Marmor, M; Del Rio, C; McElrath, MJ; Casimiro, DR; Gottesdiener, KM; Chodakewitz, JA; Corey, L; Robertson, MN (2008). "Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial". Lancet. 372 (9653): 1881–93. doi: 10.1016/S0140-6736(08)61591-3. PMC 2721012. PMID 19012954.
- ^ Korber, Bette T.; Letvin, Norman L.; Haynes, Barton F. (2009). "T-Cell Vaccine Strategies for Human Immunodeficiency Virus, the Virus with a Thousand Faces". Journal of Virology. 83 (17): 8300–8314. doi: 10.1128/JVI.00114-09. PMC 2738160. PMID 19439471.
- ^ "T-cell Vaccines Could Treat Elusive Diseases".
- ^ Commissioner, Office of the (2020-12-14). "FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine". FDA. Retrieved 2021-05-28.
- ^ Sahin, Ugur; Muik, Alexander; Derhovanessian, Evelyna; Vogler, Isabel; Kranz, Lena M.; Vormehr, Mathias; Baum, Alina; Pascal, Kristen; Quandt, Jasmin; Maurus, Daniel; Brachtendorf, Sebastian (October 2020). "COVID-19 vaccine BNT162b1 elicits human antibody and T H 1 T cell responses". Nature. 586 (7830): 594–599. Bibcode: 2020Natur.586..594S. doi: 10.1038/s41586-020-2814-7. ISSN 1476-4687. PMID 32998157.
- ^ Woldemeskel, Bezawit A.; Garliss, Caroline C.; Blankson, Joel N. (2021-05-17). "SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63". The Journal of Clinical Investigation. 131 (10). doi: 10.1172/JCI149335. ISSN 0021-9738. PMC 8121504. PMID 33822770.
.png){kind=small} | This article about COVID-19 vaccines is a stub. You can help Wikipedia by expanding it. |
 | This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it. |
A T-cell vaccine is a vaccine designed to induce protective T-cells. [1]
T-cell vaccines are designed to induce cellular immunity. They are also referred to as cell-mediated immune (CMI) vaccines. [2]
It is thought that they can be more effective than conventional B-cell vaccines for protection from microbes that hide inside host cells, and viruses (such as HIV or influenza) that mutate rapidly.[ citation needed]
T-cell vaccines underwent clinical trials for HIV/AIDS. [3]
As of July 2012 [update] none have been approved. [4]
As December 2020, The Pfizer-BioNTech Covid jab passed the FDA's emergency use authorization [5] and became the first FDA authorized T cell vaccine. [6] [7]
References
- ^ Robinson, Harriet L.; Amara, Rama Rao (2005). "T cell vaccines for microbial infections". Nature Medicine. 11 (4s): S25–S32. doi: 10.1038/nm1212. PMID 15812486. S2CID 205384682.
- ^ Buchbinder, SP; Mehrotra, DV; Duerr, A; Fitzgerald, DW; Mogg, R; Li, D; Gilbert, PB; Lama, JR; Marmor, M; Del Rio, C; McElrath, MJ; Casimiro, DR; Gottesdiener, KM; Chodakewitz, JA; Corey, L; Robertson, MN (2008). "Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial". Lancet. 372 (9653): 1881–93. doi: 10.1016/S0140-6736(08)61591-3. PMC 2721012. PMID 19012954.
- ^ Korber, Bette T.; Letvin, Norman L.; Haynes, Barton F. (2009). "T-Cell Vaccine Strategies for Human Immunodeficiency Virus, the Virus with a Thousand Faces". Journal of Virology. 83 (17): 8300–8314. doi: 10.1128/JVI.00114-09. PMC 2738160. PMID 19439471.
- ^ "T-cell Vaccines Could Treat Elusive Diseases".
- ^ Commissioner, Office of the (2020-12-14). "FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine". FDA. Retrieved 2021-05-28.
- ^ Sahin, Ugur; Muik, Alexander; Derhovanessian, Evelyna; Vogler, Isabel; Kranz, Lena M.; Vormehr, Mathias; Baum, Alina; Pascal, Kristen; Quandt, Jasmin; Maurus, Daniel; Brachtendorf, Sebastian (October 2020). "COVID-19 vaccine BNT162b1 elicits human antibody and T H 1 T cell responses". Nature. 586 (7830): 594–599. Bibcode: 2020Natur.586..594S. doi: 10.1038/s41586-020-2814-7. ISSN 1476-4687. PMID 32998157.
- ^ Woldemeskel, Bezawit A.; Garliss, Caroline C.; Blankson, Joel N. (2021-05-17). "SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63". The Journal of Clinical Investigation. 131 (10). doi: 10.1172/JCI149335. ISSN 0021-9738. PMC 8121504. PMID 33822770.
|
| This article about COVID-19 vaccines is a stub. You can help Wikipedia by expanding it. |
|
| This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it. |